Chinese Cell Therapy Firm JW Therapeutics Closes $90 Million Series A Financing

Chinese cell therapy company JW Therapeutics (Shanghai) Co., Ltd announced that it has raised a US$90 million series A found led by investors Temasek, Sequoia Capital China, and YuanMing Capital, a Beijing-based US dollar fund focusing on investments in pharmaceutical research and development, medical devices and services in both China and the U.S.

Singapore’s Temasek Leads $100M Round In Chinese Robotics Firm Rokid

Singapore’s Temasek Holdings has led a new funding round in Rokid, a Chinese robotics start-up. Investors including Credit Suisse Group, CDIB Capital International, and existing investor IDG Capital also participated in the round, Rokid announced on its Wechat official account. The company did not disclose the amount it raised, but Chinese media reports put the number at US$100 million. Rokid did not immediately respond to China Money Network’s inquiry to confirm the figure. The new round values the company at …

WuXi NextCODE Raises $75M Round Led By Temasek And Yunfeng Capital

WuXi NextCODE, a contract genomics organization and a unit under Wuxi AppTec, has closed a US$75 million series B financing co-led by Temasek Holdings and Yunfeng Capital. Other investors, including Amgen Ventures, a corporate venture capital fund established by Amgen Inc., and 3W Partners, a Greater China and cross-border focused private equity firm, also participated in the round. "We are building the world’s leading genomic data platform, applying genome sequencing data at scale to improve human health and wellness around …

Temasek Invests In Mobike To Bring 2017 Total Funding To $300M For Bike Share Firm

Chinese bike sharing company Mobike has received new strategic investment from Singapore’s state investment firm Temasek Holdings and existing investor Chinese investment firm Hillhouse Capital to raise a total of over US$300 million since the start of 2017, a tremendous feat for a start-up with actual operation time of less than one year.

CIC, Silk Road Fund Team Up With ARM To Establish $800M Innovation Fund

China Investment Corporation, Silk Road Fund, Singapore’s Temasek Holdings, ARM Holdings plc and two other investors have established a fund targeted to raise US$800 million to invest in the mobile Internet, Internet-of-Things (IoT) and artificial intelligence sectors globally. Shenzhen government-owned conglomerate Shum Yip Group Ltd. and Chinese private equity firm Hopu Investment Management Co are also backers of the Shenzhen-based vehicle named Hou An Innovation Fund, according to an announcement posted on China’s Ministry of Science and Technology’s website. ARM …

Temasek Among Bidders To Buy 10% Of China’s Postal Savings Bank

Around six preliminary bidders, including UBS AG, Singapore’s Temasek Holdings and French bank BNP Paribas, are to acquire up to a 10% stake in state-owned Postal Savings Bank of China (PSBC) for at least US$3 billion, according to media reports. The stake sale comes before PSBC’s planned initial public offering next year, which could raise around US$25 billion, equal to the record set by Alibaba Group Holding’s U.S. IPO last year.

Tuniu Corporation Files For $120M US IPO

Nanjing, Jiangsu province-based Chinese travel and tour service provider Tuniu Corporation has filed for a U.S. initial public offering (IPO), seeking to raise as much as US$120 million, according to a filing with the U.S. securities regulator.

Temasek Opens New Office In London

Singapore-based state investment company Temasek Holdings has opened an office in London to support its investment interests in Europe, Middle East and Africa (EMEA), according to a company announcement.

Temasek Names Lim Boon Heng As New Chairman

Temasek Holdings says 65-year-old Lim Boon Heng is to become its fourth chairman on August 1, succeeding S. Dhanabalan, who served as the Singaporean sovereign wealth fund’s chairman for the past 17 years. S. Dhanabalan will be retiring from Temasek’s board ahead of his 76th birthday in early August.